Novartis
Novartis AG is a Swiss multinational pharmaceutical corporation researching, manufacturing, and marketing innovative prescription therapeutics across cardiovascular, immunology, neuroscience, and oncology therapeutic areas. The company commercializes innovative medicines including Entresto for heart failure, Cosentyx for autoimmune diseases, Kesimpta for multiple sclerosis, and advanced cell and gene therapies like Kymriah and Zolgensma. Main revenue drivers comprise global commercial sales of innovative prescription biopharmaceuticals, targeted oncology drugs, and advanced radieligand therapies. Novartis serves clinical specialists, hospital networks, prescription pharmacies, and patients across Europe, North America, Asia-Pacific, and Latin America. The enterprise holds a world-dominant market position in prescription pharmaceuticals, cardiovascular treatments, and cell and gene therapies. Headquartered in Basel, Switzerland, Novartis AG is listed on the SIX Swiss Exchange and the New York Stock Exchange.
166 of the funds FundTelligence covers report a position in Novartis.
- Sector
- Health Care
- Country
- Switzerland
- Funds holding it
- 166
- Exposure themes
- Multiple, Treatment, Women's Health
Funds holding Novartis
- BlackRock iShares MSCI Europe Health Care Sector UCITS ETF — BlackRock · 15.06 % (full portfolio disclosed, October 2026)
- Fidelity Switzerland Fund — Fidelity · 8.9 % (largest positions only, October 2026)
- BlackRock iShares MSCI World Health Care Sector ESG UCITS ETF — BlackRock · 5.14 % (full portfolio disclosed, October 2026)
- AB International Health Care Portfolio — AllianceBernstein · 4.49 % (largest positions only, September 2026)
- Fondita Healthcare — Fondita · 4.4 % (largest positions only, October 2026)
- DNB Fund Women's Health — DNB · 4.34 % (full portfolio disclosed, August 2026)
- UBS Sustainable Health Transformation Equity Fund — UBS · 4.3 % (largest positions only, September 2026)
- BGF World Healthscience Fund — BlackRock · 4.08 % (largest positions only, October 2026)
Showing the 8 largest of 166 funds holding it.